Table 1.
Demographic Data of the study group.
| AGE | YRS 65 ± 9 |
|---|---|
| Men | 20(90%) |
| Diabetes, | 14(63%) |
| Hypertension | 14(63%) |
| Smoking Status | |
| Active smoking | 6(27.2%) |
| Ex smoker | 7(31.8%) |
| Nonsmoker | 9(40.9%) |
| Dyslipidemia | 13(59.09%) |
| Family history of CAD | 8(36.3%) |
| Previous Angina | |
| CCS I | 9(40.9%) |
| CCS II | 7(31.8%) |
| CCS III | 3 (13.6%) |
| CCS IV | 3 (13.6%) |
| Medications | |
| ASA | 20(90%) |
| Clopidogrel, | 13(59%) |
| Beta-blockers, | 14(63.6%) |
| RAAS antagonist, | 15(68.1%) |
| Calcium-channel blockers | 6(27.2%) |
| Statins | 18(81.8%) |
| Prior MI—remote area | 8(36.3%) |
| Previous PCI | 15(68.1%) |
| % stenosis visual estimation | 58 ± 19 |
| Ejection fraction% | 61 ± 12 |
| Target vessel | |
| LAD | 17(56.6%) |
| LCX | 7(23%) |
| RCA | 6(20%) |
| QCA | 64.6 ± 12.5 |
Note: Values are mean SD or n (%).
Abbreviations: ASA, acetylsalicylic acid; MI, myocardial infarction; PCI, percutaneous coronary intervention.